Merck Q3 Earnings & Sales Top, Stock Down on Lowered '24 View

Merck (MRK) reported third-quarter 2024 adjusted earnings of $1.57 per share, which beat the Zacks Consensus Estimate of $1.50. Earnings declined 26% year over year on a reported basis and 23% excluding foreign exchange (Fx) impact due to one-time charges incurred by the company related to business development.Revenues rose 4% year over year (7% excluding Fx) to $16.66 billion. Sales also beat the Zacks Consensus Estimate of $16.55 billion.All sales growth numbers discussed below are on a year-over-year bas ...